# Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study

> **NCT05381311** · — · COMPLETED · sponsor: **Astellas Pharma Global Development, Inc.** · enrollment: 1020 (actual)

## Conditions studied

- Prostate Cancer
- Metastatic Hormone-sensitive Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05381311
- **Lead sponsor:** Astellas Pharma Global Development, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-03
- **Primary completion:** 2022-12-11
- **Final completion:** 2022-12-11
- **Target enrollment:** 1020 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05381311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05381311, "Survey Based Discrete Choice Experiment Study in Prostate Cancer (DECIDER) Study". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT05381311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*